Alpha Cognition Operating Income 2020-2024 | ACOG
Alpha Cognition operating income from 2020 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Alpha Cognition Annual Operating Income
(Millions of US $) |
| 2023 |
$-10 |
| 2022 |
$-14 |
| 2021 |
$-12 |
| 2020 |
$-6 |
| 2019 |
$-6 |
Alpha Cognition Quarterly Operating Income
(Millions of US $) |
| 2024-06-30 |
$-2 |
| 2024-03-31 |
$-4 |
| 2023-12-31 |
$-2 |
| 2023-09-30 |
$-3 |
| 2023-06-30 |
$-3 |
| 2023-03-31 |
$-2 |
| 2022-12-31 |
$-3 |
| 2022-09-30 |
$-3 |
| 2022-06-30 |
$-4 |
| 2022-03-31 |
$-3 |
| 2021-12-31 |
$-4 |
| 2021-09-30 |
$-3 |
| 2021-06-30 |
$-2 |
| 2021-03-31 |
$-2 |
| 2020-12-31 |
$-2 |
| 2020-09-30 |
$-2 |
| 2020-06-30 |
$-2 |
| 2020-03-31 |
$-1 |
| 2019-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.035B |
$0.000B |
|
Alpha Cognition Inc. is a clinical stage biopharmaceutical company. It involved in developing treatments for under-served neurodegenerative diseases, such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. Alpha Cognition Inc. is based in Vancouver, British Columbia.
|
